BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells
暂无分享，去创建一个
J. Swantek | A. Schnapp | D. White | M. Kashem | E. Wex | A. Braun | D. Lamb | T. Bouyssou | M. Panzenbeck | M. Canfield | D. Souza | S. Wollin | K. Erb | G. Rast | T. Kono | M. Hoffmann | K. Sewald | O. Danov | Helena Obernolte | D. Bischoff | Mary Sanville-Ross | Gerd-Michael Maier | Eva Thaler | S. Blum | B. Guilliard | C. Strasser | Helga Nickel | Oliver Radmacher | H. Haas | G. Schaenzle | H. Obernolte | Christine Strasser | Bernd Guilliard | Eva Wex